NETRIS PHARMA

NETRIS PHARMA is a biotech company in Lyon, France, founded in 2008. It has raised $8.7M across 1 round, most recently an $8.7M Extension Round in December 2023.

Overcome cancer resistance

Headquarters
Lyon
Employees
11–50
Founded
2008
Business Model
B2B
Total Funding
$8.7M
Last Round
$8.7M Extension RoundDec 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

NETRIS Pharma is a clinical-stage biopharmaceutical company based in Lyon, France, developing first-in-class therapeutics that target Netrin-1 to overcome cancer resistance to chemotherapy, targeted therapy, and immunotherapy. Officially created in 2008 as the first spin-off of Centre Leon Berard and the Cancer Research Center of Lyon (CRCL), the company holds a worldwide-exclusive patent portfolio on dependence-receptor biology and partners with leading clinical, research, and corporate organizations to advance its pipeline.

Summary

It lists 11–50 employees. It has raised $8.7M in total across 1 round, most recently a $8.7M Extension Round in Dec 2023. Investors include EIC Fund.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries A ExtensionDec 2023
$8.7M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NETRIS PHARMA on Indexed.vc
<a href="https://indexed.vc/companies/netris-pharma"><img src="https://indexed.vc/api/badge/company/netris-pharma" alt="NETRIS PHARMA on Indexed.vc" width="260" height="76" /></a>